Paper Details

  1. Home
  2. Paper Details

Rizatriptan RPD for severe migraine in the emergency department--a multicenter study.

Author: BokishNatalia, DashkovskyElla, DerazonHashmonai, HayEmile, HussainAmer, KafkaMichael, KopelovitchGiorgio, NassimyanShoshana, RodrigJoseph, ShtibelmanIrina

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

This study evaluated the effectiveness of rizatriptan RPD wafers in treating severe migraine in the Emergency Department (ED). The study found that rizatriptan RPD was very effective in providing pain relief and symptom reduction within 2 hours. The medication was well-tolerated and had a low rate of headache recurrence.
Paper Details　
Original Abstract of the Article :
Many patients with severe migraine come to the Emergency Department (ED) due to failure of different drug regimens to stop their headache. We treated 98 patients with severe migraine who were seen in three different EDs. We used rizatriptan RPD wafers 10 mg and observed the patients for 2 h. We foun...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0736-4679(03)00197-5

データ提供：米国国立医学図書館（NLM）

Rizatriptan RPD: A Fast and Effective Treatment for Severe Migraine in the Emergency Department

Migraine is a debilitating condition that can significantly impact a person's quality of life. This research investigates the effectiveness of [rizatriptan RPD wafers] in treating [severe migraine] in the [Emergency Department (ED)]. The study enrolled [98 patients] with severe migraine who presented to three different EDs. The researchers found that [rizatriptan RPD was very effective and reliable] in providing [pain relief and symptom improvement] in patients with severe migraine. The study also found that [rizatriptan RPD was well-tolerated], with [minor and transient side effects].

Rizatriptan RPD: A Promising Treatment for Severe Migraine

The study's findings suggest that [rizatriptan RPD is a highly effective and well-tolerated treatment] for severe migraine in the ED. The study's results demonstrate the rapid onset of action and high rate of pain relief associated with rizatriptan RPD, offering patients with severe migraine a promising treatment option.

Navigating the Challenges of Migraine

Migraine is a common and often debilitating condition. This research highlights the potential of rizatriptan RPD as a fast and effective treatment option for severe migraine in the ED. Remember, just as a traveler in a desert might encounter various challenges, managing migraine often requires a multi-faceted approach, considering the individual needs of each patient.

Dr.Camel's Conclusion

The study's findings suggest that rizatriptan RPD is a highly effective and well-tolerated treatment for severe migraine in the ED. The research underscores the importance of exploring new and effective treatment options for migraine, offering patients a path to relief and improved quality of life. Remember, just as the desert holds hidden oases of beauty and serenity, the world of medicine is constantly seeking ways to alleviate pain and suffering.

Date :
  1. Date Completed 2004-05-17
  2. Date Revised 2019-09-06
Further Info :

Pubmed ID

14585450

DOI: Digital Object Identifier

10.1016/s0736-4679(03)00197-5

Related Literature

Article Analysis
・Side Effects of rizatriptan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.